These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1797420)

  • 21. Structural basis for endotoxic and antagonistic activities: investigation with novel synthetic lipid A analogs.
    Kusumoto S; Fukase K; Fukase Y; Kataoka M; Yoshizaki H; Sato K; Oikawa M; Suda Y
    J Endotoxin Res; 2003; 9(6):361-6. PubMed ID: 14733722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biological activity of chemically synthesized core sugar linked lipid A analog, heptose-(alpha 1----5)-2-keto-3-deoxyoctonic acid-(alpha 2----6)-2,3-diacyloxyacylglucosamine-4-phosphate.
    Shimizu T; Ohtsuka Y; Yanagihara Y; Akamatsu S; Ikeda K; Achiwa K
    Int J Immunopharmacol; 1992 Feb; 14(2):221-6. PubMed ID: 1624222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiviral and immunomodulating activities of chemically synthesized lipid A-subunit analogues GLA-27 and GLA-60.
    Ikeda S; Nishimura C; Nakatsuka M; Homma JY; Kiso M; Hasegawa A
    Antiviral Res; 1988; 9(1-2):37-46. PubMed ID: 3389769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mitogenic activity and lethal toxicity of lipid A analogs, glucosamine-phosphate carrying aromatic alkyl groups, in mice.
    Shimizu T; Iwamoto Y; Yanagihara Y; Itoh H; Nakamoto S; Achiwa K
    Biol Pharm Bull; 1993 Sep; 16(9):932-4. PubMed ID: 8268863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antitumor effect of DT-5461, a lipid A derivative, against human tumor xenografts is mediated by intratumoral production of tumor necrosis factor and affected by host immunosuppressive factors in nude mice.
    Kumazawa E; Jimbo T; Akimoto T; Joto N; Tohgo A
    Cancer Invest; 1997; 15(6):522-30. PubMed ID: 9412657
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthetic lipid A with endotoxic and related biological activities comparable to those of a natural lipid A from an Escherichia coli re-mutant.
    Kotani S; Takada H; Tsujimoto M; Ogawa T; Takahashi I; Ikeda T; Otsuka K; Shimauchi H; Kasai N; Mashimo J
    Infect Immun; 1985 Jul; 49(1):225-37. PubMed ID: 3891627
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antitumor activity and biological effects of chemically synthesized monosaccharide analogues of lipid A in mice.
    Shimizu T; Akiyama S; Masuzawa T; Yanagihara Y; Nakamoto S; Takahashi T; Ikeda K; Achiwa K
    Chem Pharm Bull (Tokyo); 1985 Oct; 33(10):4621-4. PubMed ID: 4092276
    [No Abstract]   [Full Text] [Related]  

  • 28. Synthesis of 2-deoxy-2-[(2R,3S)-2-fluoro-3-hydroxytetradecanamido]- 3-O-[(3R)-3-hydroxytetradecanoyl]-4-O-phosphono-D-glucopyranose and its (2S,3R)-isomer.
    Shiozaki M; Arai M; Hiraoka T; Nishijima M; Akamatsu Y
    Biosci Biotechnol Biochem; 1993 Sep; 57(9):1526-9. PubMed ID: 7764222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunopharmacological activities of 2-keto-3-deoxyoctonic acid-(alpha 2----6)-linked 4-O-phosphono-D-glucosamine derivatives carrying N- and 3-O-acyl substituents.
    Kumazawa Y; Matsuura M; Homma JY; Furuya T; Takimoto H; Inagaki K; Nagumo T; Kiso M; Hasegawa A
    Infect Immun; 1989 Jun; 57(6):1845-8. PubMed ID: 2785963
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 3-O-Desacyl monophosphoryl lipid A derivatives: synthesis and immunostimulant activities.
    Johnson DA; Keegan DS; Sowell CG; Livesay MT; Johnson CL; Taubner LM; Harris A; Myers KR; Thompson JD; Gustafson GL; Rhodes MJ; Ulrich JT; Ward JR; Yorgensen YM; Cantrell JL; Brookshire VG
    J Med Chem; 1999 Nov; 42(22):4640-9. PubMed ID: 10579826
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthetic Salmonella-type lipid A antigen with high serological specificity.
    Kasai N; Arata S; Mashimo J; Okuda K; Aihara Y; Kotani S; Takada H; Shiba T; Kusumoto S; Imoto M
    Infect Immun; 1986 Jan; 51(1):43-8. PubMed ID: 3941004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunobiologically active lipid A analogs synthesized according to a revised structural model of natural lipid A.
    Kotani S; Takada H; Tsujimoto M; Ogawa T; Harada K; Mori Y; Kawasaki A; Tanaka A; Nagao S; Tanaka S
    Infect Immun; 1984 Jul; 45(1):293-6. PubMed ID: 6735470
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DT-5461a, an antitumor synthetic lipid a analog, causes selective blood flow reduction in tumor tissue.
    Akimoto T; Kumazawa E; Jimbo T; Joto N; Tohgo A
    Anticancer Res; 1995; 15(1):105-7. PubMed ID: 7537483
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural requirements for inducing in vitro B lymphocyte activation by chemically synthesized derivatives related to the nonreducing D-glucosamine subunit of lipid A.
    Kumazawa Y; Matsuura M; Maruyama T; Homma JY; Kiso M; Hasegawa A
    Eur J Immunol; 1986 Sep; 16(9):1099-103. PubMed ID: 3489621
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antitumor activity and lethal toxicity of chemically synthesized tetraacetyl-2-keto-3-deoxyoctonic acid-(alpha 2---6)-D-glucosamine analogues of lipid A.
    Shimizu T; Akiyama S; Masuzawa T; Yanagihara Y; Nakamoto S; Achiwa K
    Chem Pharm Bull (Tokyo); 1987 Feb; 35(2):873-6. PubMed ID: 3594698
    [No Abstract]   [Full Text] [Related]  

  • 36. Low endotoxic activities of synthetic Salmonella-type lipid A with an additional acyloxyacyl group on the 2-amino group of beta (1-6) glucosamine disaccharide 1,4'-bisphosphate.
    Kotani S; Takada H; Takahashi I; Tsujimoto M; Ogawa T; Ikeda T; Harada K; Okamura H; Tamura T; Tanaka S
    Infect Immun; 1986 Jun; 52(3):872-84. PubMed ID: 3011676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endotoxic properties of chemically synthesized lipid A part structures. Comparison of synthetic lipid A precursor and synthetic analogues with biosynthetic lipid A precursor and free lipid A.
    Galanos C; Lehmann V; Lüderitz O; Rietschel ET; Westphal O; Brade H; Brade L; Freudenberg MA; Hansen-Hagge T; Lüderitz T
    Eur J Biochem; 1984 Apr; 140(2):221-7. PubMed ID: 6714230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhancement of nonspecific resistance to viral infection by chemically synthesized lipid A-subunit analogs with different backbone structures and acyl groups.
    Ikeda S; Kumazawa Y; Nishimura C; Nakatsuka M; Homma JY; Kiso M; Hasegawa A
    Antiviral Res; 1988 Dec; 10(4-5):167-78. PubMed ID: 2465734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interferon-inducing, pyrogenic and proclotting enzyme of horseshoe crab activation activities of chemically synthesized lipid A analogues.
    Matsuura M; Kojima Y; Homma JY; Kubota Y; Shibukawa N; Shibata M; Inage M; Kusumoto S; Shiba T
    Eur J Biochem; 1983 Dec; 137(3):639-42. PubMed ID: 6600151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficient synthesis of novel monosaccharide analogs of lipids A.
    Nakamoto S; Takahashi T; Ikeda K; Achiwa K
    Chem Pharm Bull (Tokyo); 1985 Sep; 33(9):4098-101. PubMed ID: 4092305
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.